Reverse Genetics To Forward The Pan-Lassa Fever Vaccine Lead Candidate ML29

Project: Other project

StatusActive
Effective start/end date8/1/187/31/20

Funding

  • National Inst of Allergy & Infectious Di: $161,945.41